aTyr Pharma
Latest round
- Series E
Last raised
- Mar 2015
Total raised
- $171M
Investors
- 12
About aTyr Pharma
Based in the US, aTyr Pharma, Inc.Founded in 2005 and headquartered in San Diego, California, aTyr Pharma, Inc. operates as a biotechnology firm that develops therapies for chronic inflammatory diseases. The leadership team includes CEO Jangwon Yoon and Sanjay Shukla, who have backgrounds in the biotechnology sector.aTyr Pharma specializes in leveraging tRNA synthetase biology to develop innovative therapies aimed at treating fibrosis and inflammation-related conditions. The company's flagship product, Efzofitimod, is designed to target specific pathways involved in pulmonary sarcoidosis and systemic sclerosis-associated interstitial lung disease (SSc-ILD). These therapies work by modulating immune responses and promoting tissue repair, addressing significant unmet medical needs in patients suffering from these debilitating diseases. aTyr Pharma serves a diverse client base that includes healthcare providers, research institutions, and pharmaceutical partners, primarily in North America and Europe.aTyr Pharma's revenue generation for the year 2024 is reported at USD 235,000, with an EBITDA of USD -67,206,000. The firm's revenue model is primarily driven by partnerships and collaborations with other biotechnology and pharmaceutical companies, as well as through clinical trial sponsorships.aTyr Pharma aims to further enhance its portfolio with the development and launch of new products tailored for chronic inflammatory conditions.
Who invested in aTyr Pharma
12 investors across 6 rounds
See all investors in aTyr Pharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about aTyr Pharma
Who invested in aTyr Pharma?
aTyr Pharma has 12 investors on record across 6 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has aTyr Pharma raised?
aTyr Pharma has raised 6 venture rounds. Sign up free to see how much each round raised and the total.
When did aTyr Pharma last raise money?
aTyr Pharma's most recent round on record is a Series E, in Mar 2015.
What does aTyr Pharma do?
Based in the US, aTyr Pharma, Inc.
Where is aTyr Pharma headquartered?
aTyr Pharma is headquartered in San Diego, US.
Which VCs invest in companies like aTyr Pharma?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at aTyr Pharma's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series E
Raising like aTyr Pharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.